SynphaBase AG

SynphaBase AG is a Swiss-based custom research and development organization (CRDO) specializing in medicinal chemistry, process R&D, and glycoscience, including high-purity carbohydrate synthesis. Established in 2000 and servicing pharma, biotech, fine chemicals, and academic sectors, the company offers integrated support from early-stage route scouting to GMP-grade manufacturing in partnership with CMOs. With over 2,000 completed projects (from milligram to multi‑kilogram, GMP & non‑GMP) as of ~2024, SynphaBase emphasizes process optimization, reproducibility, and structural precision tailored to complex molecule types. Innovation focuses heavily on oligosaccharides and carbohydrate-conjugates. Synphabase operate under an ISO 9001:2015-certified quality management system and are authorized by Swissmedic to support GMP-compliant processes through qualified contract manufacturing partners (CMOs).